A pediatric dermatologist reviews the case of a 25-year-old female with a history of vitiligo since adolescence who is affected by the social stigma of the condition.
Exploring Afamelanotide for Vitiligo: Insights into the CUV 105 Phase 3 Clinical Trial
The Cutaneous Connection: Enhancing Vitiligo Care With Nanette Silverberg, MD
Researchers Report Case of Patient With Mogamulizumab-Induced Vitiligo
ReV Up Your Vitiligo Treatment Strategies
Exploring Genetic Factors in Vitiligo and AA
Discovering Dermatology Times: August 2024 Personalized Vitiligo Care Supplement